Publicaciones en las que colabora con GUILLERMO QUINDOS ANDRES (28)

2014

  1. Candida antigens and immune responses: Implications for a vaccine

    Expert Review of Vaccines, Vol. 13, Núm. 8, pp. 1001-1012

2012

  1. Periodontopathogen and epstein-barr virus contamination affects transplanted bone volume in sinus augmentation

    Journal of Periodontology, Vol. 83, Núm. 2, pp. 162-173

2011

  1. Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 7, pp. 3156-3163

2009

  1. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity

    Journal of Medical Microbiology, Vol. 58, Núm. 11, pp. 1437-1442

2007

  1. Identificación rápida de Candida dubliniensis mediante la prueba Bichro-Dubli®

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 9, pp. 576-578

2006

  1. Diagnostic potential of (1→3)-β-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients

    Revista Iberoamericana de Micologia, Vol. 23, Núm. 4, pp. 209-215

  2. Evaluation of Bichro-Dubli Fumouze® to distinguish Candida dubliniensis from Candida albicans

    Diagnostic Microbiology and Infectious Disease, Vol. 55, Núm. 2, pp. 165-167

  3. Evaluation of the new chromogenic medium candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species

    Journal of Clinical Microbiology, Vol. 44, Núm. 9, pp. 3340-3345

  4. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: Comparison of CLSI M27-A2, Sensitive YeastOne, disk diffusion, and Etest methods

    Microbial Drug Resistance, Vol. 12, Núm. 4, pp. 246-251

  5. Isolation of Issatchenkia occidentalis from the esophagus of a leukemic patient

    Revista Iberoamericana de Micologia, Vol. 23, Núm. 4, pp. 235-237

  6. Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis

    Medical Mycology, Vol. 44, Núm. 7, pp. 611-615

2005

  1. Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico

    Journal of Clinical Microbiology, Vol. 43, Núm. 8, pp. 4159-4162

  2. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons

    Revista Iberoamericana de Micologia, Vol. 22, Núm. 2, pp. 83-92

  3. Supplementation of CHROMagar candida medium with Pal's medium for rapid identification of Candida dubliniensis

    Journal of Clinical Microbiology, Vol. 43, Núm. 11, pp. 5768-5770

2004

  1. Evaluación de una nueva técnica comercializada (Candida albicans IFA IgG) para el diagnóstico de la candidiasis invasiva

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 2, pp. 83-88

  2. Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis

    Diagnostic Microbiology and Infectious Disease, Vol. 50, Núm. 3, pp. 219-221

  3. Is there a role for antibody testing in the diagnosis of invasive candidiasis?

    Revista Iberoamericana de Micologia, Vol. 21, Núm. 1, pp. 10-14

  4. The role of antigen and antibody testing in the diagnosis of invasive candidiasis

    Mikologia Lekarska, Vol. 11, Núm. 2, pp. 145-151

2001

  1. Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infections

    Journal of Clinical Microbiology, Vol. 39, Núm. 8, pp. 2999-3001

  2. Specific antibody response in a patient with Candida dubliniensis fungemia

    Revista Iberoamericana de Micologia, Vol. 18, Núm. 1, pp. 42-44